Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “derivative”

1,342 pharma patents match "derivative" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,342
Index total 30,257
Page 9 / 56

Quick answer

This filtered view shows 1,342 pharmaceutical patents matching "derivative" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,342 results for “derivative” · 30,257 patents in full index Clear search

  1. US 11066378

    Caffeic acid derivatives for anti-angiogenesis

    China Medical University · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted
  2. US 11052057

    Use of cysteamine and derivatives thereof to suppress tumor metastases

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  3. US 11045472

    Quinazoline-pyridine derivatives for the treatment of cancer-related disorders

    Arcus Biosciences, Inc. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  4. US 11046691

    2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors

    IDEAYA Biosciences, Inc. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  5. US 11040998

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  6. US 11040028

    Penicinotam derivative, preparation method and use thereof

    OCEAN UNIVERSITY OF CHINA · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  7. US 11034705

    Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors

    NIKANG THERAPEUTICS, INC. · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  8. US 11028083

    Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases

    The Board of Regents of the University of Texas System · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted
  9. US 11021454

    Type of aryl benzofuran amidated derivative and medical use thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  10. US 11008360

    Indoleacetic acid derivative and preparation method and pharmaceutical use thereof

    Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences · Granted May 18, 2021 · Expires May 13, 2041

    granted
  11. US 10995089

    Zaindole derivatives and their use as ERK kinase inhibitors

    AGV Discovery · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  12. US 10995100

    Bicyclic heterocyclyl derivatives as IRAK4 inhibitors

    Aurigene Discovery Technologies Limited · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  13. US 10981896

    Indolinone derivatives as inhibitors of maternal embryonic leucine zipper kinase

    The Board of Regents of the University of Texas System · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  14. US 10981855

    Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders

    PTC THERAPEUTICS, INC. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  15. US 10982221

    Plant-derived antibodies and derivatives that reduce risk of antibody-dependent enhancement (ADE) of infection

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  16. US 10981866

    Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  17. US 10973805

    Macrocyclic azolopyridine derivatives as EED and PRC2 modulators

    Fulcrum Therapeutics, Inc. · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted
  18. US 10968166

    4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

    PTC THERAPEUTICS, INC. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  19. US 10968180

    Piperidine derivatives as HDAC1/2 inhibitors

    Regenacy Pharmaceuticals, Inc. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  20. US 10968231

    Substituted cyclyl-acetic acid derivatives for the treatment of metabolic disorders

    Takeda Pharmaceutical Company Limited · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  21. US 10968249

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  22. US 10961205

    1,2,4-oxadiazole derivatives as immunomodulators

    Aurigene Discovery Technologies Limited · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted
  23. US 10954198

    Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases

    United Kingdom Research and Innovation · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted
  24. US 10941128

    Thymoquinone derivatives for treatment of cancer

    UNITED ARAB EMIRATES UNIVERSITY · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted